vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Donnelley Financial Solutions, Inc. (DFIN). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $172.5M, roughly 1.1× Donnelley Financial Solutions, Inc.). Donnelley Financial Solutions, Inc. runs the higher net margin — 3.6% vs -14.6%, a 18.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 10.4%). Donnelley Financial Solutions, Inc. produced more free cash flow last quarter ($47.9M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -7.9%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Donnelley Financial Solutions (DFIN) is a financial compliance company based in Chicago, Illinois, United States. The company provides software as a service (SaaS) products, software-enabled services (SeS), print, and compliance services related to US Securities and Exchange Commission regulations to companies in capital and investment markets.
AXSM vs DFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $172.5M |
| Net Profit | $-28.6M | $6.2M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 8.3% |
| Net Margin | -14.6% | 3.6% |
| Revenue YoY | 65.0% | 10.4% |
| Net Profit YoY | 61.9% | -1.6% |
| EPS (diluted) | $-0.55 | $0.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $172.5M | ||
| Q3 25 | $171.0M | $175.3M | ||
| Q2 25 | $150.0M | $218.1M | ||
| Q1 25 | $121.5M | $201.1M | ||
| Q4 24 | $118.8M | $156.3M | ||
| Q3 24 | $104.8M | $179.5M | ||
| Q2 24 | $87.2M | $242.7M | ||
| Q1 24 | $75.0M | $203.4M |
| Q4 25 | $-28.6M | $6.2M | ||
| Q3 25 | $-47.2M | $-40.9M | ||
| Q2 25 | $-48.0M | $36.1M | ||
| Q1 25 | $-59.4M | $31.0M | ||
| Q4 24 | $-74.9M | $6.3M | ||
| Q3 24 | $-64.6M | $8.7M | ||
| Q2 24 | $-79.3M | $44.1M | ||
| Q1 24 | $-68.4M | $33.3M |
| Q4 25 | -13.8% | 8.3% | ||
| Q3 25 | -27.0% | 16.1% | ||
| Q2 25 | -24.5% | 24.2% | ||
| Q1 25 | -46.9% | 22.8% | ||
| Q4 24 | -61.1% | 6.0% | ||
| Q3 24 | -59.8% | 10.1% | ||
| Q2 24 | -89.5% | 26.6% | ||
| Q1 24 | -89.7% | 21.9% |
| Q4 25 | -14.6% | 3.6% | ||
| Q3 25 | -27.6% | -23.3% | ||
| Q2 25 | -32.0% | 16.6% | ||
| Q1 25 | -48.9% | 15.4% | ||
| Q4 24 | -63.1% | 4.0% | ||
| Q3 24 | -61.7% | 4.8% | ||
| Q2 24 | -91.0% | 18.2% | ||
| Q1 24 | -91.1% | 16.4% |
| Q4 25 | $-0.55 | $0.31 | ||
| Q3 25 | $-0.94 | $-1.49 | ||
| Q2 25 | $-0.97 | $1.28 | ||
| Q1 25 | $-1.22 | $1.05 | ||
| Q4 24 | $-1.54 | $0.21 | ||
| Q3 24 | $-1.34 | $0.29 | ||
| Q2 24 | $-1.67 | $1.47 | ||
| Q1 24 | $-1.44 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $24.5M |
| Total DebtLower is stronger | — | $171.3M |
| Stockholders' EquityBook value | $88.3M | $379.2M |
| Total Assets | $689.8M | $800.4M |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $24.5M | ||
| Q3 25 | $325.3M | $22.7M | ||
| Q2 25 | $303.0M | $33.8M | ||
| Q1 25 | $300.9M | $16.2M | ||
| Q4 24 | $315.4M | $57.3M | ||
| Q3 24 | $327.3M | $33.6M | ||
| Q2 24 | $315.7M | $35.0M | ||
| Q1 24 | $331.4M | $43.7M |
| Q4 25 | — | $171.3M | ||
| Q3 25 | — | $154.7M | ||
| Q2 25 | — | $190.1M | ||
| Q1 25 | — | $189.5M | ||
| Q4 24 | — | $124.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $88.3M | $379.2M | ||
| Q3 25 | $73.7M | $423.1M | ||
| Q2 25 | $73.1M | $432.1M | ||
| Q1 25 | $53.2M | $419.9M | ||
| Q4 24 | $57.0M | $436.1M | ||
| Q3 24 | $92.9M | $444.5M | ||
| Q2 24 | $102.9M | $441.5M | ||
| Q1 24 | $144.0M | $408.9M |
| Q4 25 | $689.8M | $800.4M | ||
| Q3 25 | $669.3M | $816.3M | ||
| Q2 25 | $639.8M | $874.7M | ||
| Q1 25 | $596.7M | $852.8M | ||
| Q4 24 | $568.5M | $841.6M | ||
| Q3 24 | $561.5M | $843.6M | ||
| Q2 24 | $548.2M | $882.9M | ||
| Q1 24 | $545.7M | $867.8M |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.37× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $59.8M |
| Free Cash FlowOCF − Capex | $-18.7M | $47.9M |
| FCF MarginFCF / Revenue | -9.6% | 27.8% |
| Capex IntensityCapex / Revenue | 0.0% | 6.9% |
| Cash ConversionOCF / Net Profit | — | 9.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $59.8M | ||
| Q3 25 | $1.0M | $74.4M | ||
| Q2 25 | $-32.4M | $68.4M | ||
| Q1 25 | $-43.4M | $-37.7M | ||
| Q4 24 | $-26.2M | $56.4M | ||
| Q3 24 | $-18.6M | $86.4M | ||
| Q2 24 | $-30.1M | $56.2M | ||
| Q1 24 | $-53.5M | $-27.9M |
| Q4 25 | $-18.7M | $47.9M | ||
| Q3 25 | $988.0K | $59.2M | ||
| Q2 25 | $-32.4M | $51.7M | ||
| Q1 25 | $-43.7M | $-51.0M | ||
| Q4 24 | $-26.2M | $41.3M | ||
| Q3 24 | $-18.7M | $67.3M | ||
| Q2 24 | $-30.2M | $36.8M | ||
| Q1 24 | $-53.6M | $-40.2M |
| Q4 25 | -9.6% | 27.8% | ||
| Q3 25 | 0.6% | 33.8% | ||
| Q2 25 | -21.6% | 23.7% | ||
| Q1 25 | -36.0% | -25.4% | ||
| Q4 24 | -22.1% | 26.4% | ||
| Q3 24 | -17.9% | 37.5% | ||
| Q2 24 | -34.6% | 15.2% | ||
| Q1 24 | -71.4% | -19.8% |
| Q4 25 | 0.0% | 6.9% | ||
| Q3 25 | 0.0% | 8.7% | ||
| Q2 25 | 0.0% | 7.7% | ||
| Q1 25 | 0.3% | 6.6% | ||
| Q4 24 | 0.0% | 9.7% | ||
| Q3 24 | 0.1% | 10.6% | ||
| Q2 24 | 0.1% | 8.0% | ||
| Q1 24 | 0.1% | 6.0% |
| Q4 25 | — | 9.65× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.89× | ||
| Q1 25 | — | -1.22× | ||
| Q4 24 | — | 8.95× | ||
| Q3 24 | — | 9.93× | ||
| Q2 24 | — | 1.27× | ||
| Q1 24 | — | -0.84× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
